Biosimilars - a Regulatory Overview and Market Review July 8, 2012

Biosimilars have attracted a great deal of interest recently and are seen by some as the new generic frontier. This masterclass will look at the regulatory barriers to entry as well as what has actually occurred in markets where Biosimilars have been launched. The programme also includes a look into what the future might bring in terms of a US Biosimilars pathway and competition for the high price Monoclonal antibody products that many Biosimilar companies are targeting.

Benefits of attending:
• Receive a good overview of the Biosimilars picture across the world
• Develop an insight into the varying regulatory approaches prevailing in different regions
• Demonstrate an understanding of the commercial situation as it is now and likely to develop in the future
• Gain enough background to determine whether entering the biosimilars market is an appropriate strategy for your company
• Collect valuable CPD points through attendance

To find out more about this event, visit http://www.smi-online.co.uk/biosimilars-market5.asp

Alternatively, contact Vinh Trinh on +44 (0) 20 7827 6140 or email [email protected]

Official Website: http://www.smi-online.co.uk/biosimilars-market5.asp